From professional translators, enterprises, web pages and freely available translation repositories.
sulfonilsečnini
common
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
20 primerjalni skupini na sulfonilsečnini.
this is similar to that seen in a sulphonylurea active comparator group.
Last Update: 2011-10-23
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
dodatek k sulfonilsečnini, sami ali v kombinaciji z metforminom
add-on to sulphonylurea alone or in combination with metformin
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
empagliflozin kot dodatno zdravljenje k metforminu, sulfonilsečnini, pioglitazonu
empagliflozin as add-on to metformin, sulphonylurea, pioglitazone
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
to je podobno opažanjem v aktivni primerjalni skupini na sulfonilsečnini.
this is similar to that seen in a sulphonylurea active comparator group.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
v eni študiji so linagliptin dajali kot dodatno zdravilo ob metforinu in sulfonilsečnini.
in one study linagliptin was given as add-on to metformin plus sulphonylurea.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
dodatno ob metforminu in sulfonilsečnini, dodatno ob insulinu z metforminom ali brez njega.
add-on to metformin + sulphonylurea add-on to insulin with or without metformin
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
z aktivno učinkovino kontrolirana študija v primerjavi z insulinom glarginom kot dodatkom metforminu sulfonilsečnini
active-controlled study versus insulin glargine as add-on to metformin sulphonylurea
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
v študiji dodatka metforminu in sulfonilsečnini v obdobju do 24 tednov niso zabeležili hudih hipoglikemij.
in an add-on to metformin and a sulphonylurea study, up to 24 weeks, no episodes of major hypoglycaemia were reported.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
chmp je ugotovil tudi, da je bila kombinacija vildagliptina in metformina učinkovita kot dodatek sulfonilsečnini ali insulinu.
the chmp also noted that the combination of vildagliptin and metformin was effective as an add-on to a sulphonylurea or insulin.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Če so linagliptin dodali k sulfonilsečnini ob osnovnem zdravljenju z metforminom, je bila pojavnost hipoglikemije večja kot pri placebu.
when linagliptin was added to a sulphonylurea on a background of metformin, the incidence of hypoglycaemia was increased over that of placebo.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
varnost in učinkovitost dulaglutida kot dodatka sulfonilsečnini so preučevali v študiji, nadzorovani s placebom, ki je trajala 24 tednov.
in an active controlled study of 78 weeks duration, dulaglutide was compared to insulin glargine, both on a background of metformin and a sulphonylurea.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
v preskušanjih kombiniranega zdravljenja je pioglitazon, dodan sulfonilsečnini, povzročil povprečno povečanje telesne mase v enem letu za 2,8 kg.
in combination trials pioglitazone added to a sulphonylurea resulted in a mean weight increase over one year of 2.8 kg.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
v primerjalnih skupinah je dodatek sulfonilsečnine metforminu povzročil povprečno povečanje telesne mase za 1,3 kg in dodatek metformina sulfonilsečnini povprečno zmanjšanje telesne teže za 1,0 kg.
in comparator groups addition of sulphonylurea to metformin resulted in a mean weight gain of 1.3 kg and addition of metformin to a sulphonylurea a mean weight loss of 1.0 kg.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
v primerjalnih skupinah je dodatek sulfonilsečnine k metforminu povzročil povprečno povečanje telesne mase za 1,3 kg, dodatek metformina k sulfonilsečnini pa povprečno zmanjšanje telesne mase za 1,0 kg.
in comparator groups, addition of sulphonylurea to metformin resulted in a mean weight gain of 1.3 kg and addition of metformin to a sulphonylurea a mean weight loss of 1.0 kg.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
1 ocene pogostnosti temeljijo na zbranih podatkih o samostojnem zdravljenju s saksagliptinom, kot dodatku k zdravljenju z metforninom in v uvodni kombinaciji z metforminom, kot dodatku k sulfonilsečnini in kot dodatku k tiazolidindionu v kliničnih preskušanjih.
1 frequency estimates are based on the pooled analysis of the saxagliptin monotherapy, add-on to metformin and initial combination with metformin, add-on to sulphonylurea and add-on to thiazolidinedione clinical trials.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
v preskušanjih kombiniranega zdravljenja je pioglitazon, dodan metforminu, povzročil povprečno povečanje telesne mase v enem letu za 1, 5 kg oziroma, dodan sulfonilsečnini, za 2, 8 kg.
in combination trials pioglitazone added to metformin resulted in mean weight increase over one year of 1.5 kg and added to a sulphonylurea of 2.8 kg.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
eksenatid v obliki s takojšnjim sproščanjem je zmanjšalo hba1c in telesno maso pri bolnikih, ki so jih v treh s placebom nadzorovanih študijah zdravili 30 tednov, neodvisno od tega ali je bilo eksenatid v obliki s takojšnjim sproščanjem dodano metforminu, sulfonilsečnini ali kombinaciji obeh.
immediate-release exenatide reduced hba1c and body weight in patients treated for 30 weeks in three placebo-controlled studies, whether the immediate-release exenatide was added to metformin, a sulphonylurea or a combination of both.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kot dodatek metforminu in sulfonilsečnini: omotica (pogosto), utrujenost (pogosto) in flatulenca (pogosto).
as add-on to metformin and a sulphonylurea: dizziness (common), fatigue (common) and flatulence (common).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
druga možnost je, da se actos uporablja kot dodatek k sulfonilsečnini (drugo zdravilo za sladkorno bolezen) pri bolnikih, za katere metformin ni ustrezen in ki z jemanjem samo sulfonilsečnine v največjem možnem odmerku, ki ga bolnik lahko prenaša, nimajo zadovoljivo uravnanih vrednosti krvnega sladkorja. • lahko se uporablja v kombinaciji z dvema drugima zdraviloma za sladkorno bolezen, metforminom in sulfonilsečnino, v okviru zdravljenja s tremi zdravili hkrati pri bolnikih (zlasti tistih s čezmerno telesno maso), pri katerih z uporabo teh dveh zdravil ne moremo doseči zadovoljivega nadzora. • lahko se uporablja v kombinaciji z insulinom pri bolnikih, pri katerih z jemanjem samo insulina ne moremo doseči zadovoljivega nadzora in ki ne morejo jemati metformina.
alternatively, it can be added to a sulphonylurea (another antidiabetic medicine) in patients for whom metformin is not suitable and who are not satisfactorily controlled with the sulphonylurea used on its own at the maximum tolerated dose. • it can be used together with two other antidiabetic medicines, metformin and a sulphonylurea, as triple therapy in patients (particularly those who are overweight) who are not satisfactorily controlled with these two medicines. • it can be used together with insulin in patients who are not satisfactorily controlled with insulin alone and cannot take metformin.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.